Skip to main content

International Journal of Hematology

Ausgabe 1/2011

Including PIH Articles on Seven Wonders of Erythropoiesis

Inhalt (23 Artikel)

Progress in Hematology

Guest editorial: the seven wonders of erythropoiesis

Kenichi Sawada

Progress in Hematology

Red blood cell production from immortalized progenitor cell line

Yukio Nakamura, Takashi Hiroyama, Kenichi Miharada, Ryo Kurita

Progress in Hematology

Erythropoiesis, anemia and the bone marrow microenvironment

Carl R. Walkley

Progress in Hematology

The molecular basis of iron overload disorders and iron-linked anemias

Jerry Kaplan, Diane M. Ward, Ivana De Domenico

Progress in Hematology

Iron and erythropoiesis: a dual relationship

Clara Camaschella, Alessia Pagani

Rapid Communication

Stochastic acquisition of a stem cell-like state and drug tolerance in leukemia cells stressed by radiation

Ga-Young Lee, Jae-Seung Shim, Bin Cho, Joo-Young Jung, Dong-Soon Lee, Il-Hoan Oh

Original Article

Safety and efficacy of the terminal complement inhibitor eculizumab in Japanese patients with paroxysmal nocturnal hemoglobinuria: the AEGIS Clinical Trial

Yuzuru Kanakura, Kazuma Ohyashiki, Tsutomu Shichishima, Shinichiro Okamoto, Kiyoshi Ando, Haruhiko Ninomiya, Tatsuya Kawaguchi, Shinji Nakao, Hideki Nakakuma, Jun-ichi Nishimura, Taroh Kinoshita, Camille L. Bedrosian, Marye Ellen Valentine, Gus Khursigara, Keiya Ozawa, Mitsuhiro Omine

Original Article

Elevated Von Willebrand factor propeptide for the diagnosis of thrombotic microangiopathy and for predicting a poor outcome

Naomi Ito-Habe, Hideo Wada, Takeshi Matsumoto, Kohshi Ohishi, Hidemi Toyoda, Eiji Ishikawa, Shinsuke Nomura, Yoshihiro Komada, Masaaki Ito, Tsutomu Nobori, Naoyuki Katayama

Original Article

Factor VIII concentration is greater in female than male patients with HIV infection

Alireza Abdollahi, Afsaneh Morteza, Omid Khalilzadeh, Ahmad Ahmadzadeh

Original Article

Reduced risk of bacterial infection in multiple myeloma patients with VAD regimen without intermittent high-dose dexamethasone

Atsushi Isoda, Morio Matsumoto, Hirotaka Nakahashi, Momoko Mawatari, Akihiro Manaka, Morio Sawamura

Original Article

Analysis of bacteremia/fungemia and pneumonia accompanying acute myelogenous leukemia from 1987 to 2001 in the Japan Adult Leukemia Study Group

Minoru Yoshida, Nobu Akiyama, Hiroyuki Fujita, Katsuhiro Miura, Jun-ichi Miyatake, Hiroshi Handa, Katsuyuki Kito, Masatomo Takahashi, Kazuyuki Shigeno, Yoshinobu Kanda, Naoko Hatsumi, Shigeki Ohtake, Hisashi Sakamaki, Kazunori Ohnishi, Shuichi Miyawaki, Ryuzo Ohno, Tomoki Naoe

Original Article

Telomeres and prognosis in patients with chronic lymphocytic leukaemia

Ludger Sellmann, Dirk de Beer, Marius Bartels, Bertram Opalka, Holger Nückel, Ulrich Dührsen, Jan Dürig, Marc Seifert, Dörte Siemer, Ralf Küppers, Gabriela M. Baerlocher, Alexander Röth

Original Article

Low-dose rituximab combined with short-term glucocorticoids up-regulates Treg cell levels in patients with immune thrombocytopenia

Zhenyu Li, Weiwei Mou, Guang Lu, Jiang Cao, Xupeng He, Xiuying Pan, Kailin Xu

Original Article

Quality of long-term cryopreserved umbilical cord blood units for hematopoietic cell transplantation

Shohei Yamamoto, Hirokazu Ikeda, Daisuke Toyama, Mayumi Hayashi, Kousuke Akiyama, Manabu Suzuki, Yutaka Tanaka, Tsuneki Watanabe, Yoko Fujimoto, Ichirou Hosaki, Hirokazu Nishihira, Keiichi Isoyama

Case Report

Molecular analysis of a patient with type I Glanzmann thrombasthenia and clinical impact of the presence of anti-αIIbβ3 alloantibodies

Hirokazu Kashiwagi, Kazunobu Kiyomizu, Tsuyoshi Kamae, Tsuyoshi Nakazawa, Seiji Tadokoro, Shuji Takiguchi, Yuichiro Doki, Yuzuru Kanakura, Yoshiaki Tomiyama

Case Report

Concurrent development of “Burkitt-like” lymphoma and BCL-2-rearranged low-grade B cell lymphoma sharing the same germinal center origin

Hiroshi Kobayashi, Motoshi Ichikawa, Akira Hangaishi, Yoichi Imai, Mineo Kurokawa

Case Report

Repeated donor lymphocyte infusions overcome a myeloid sarcoma of the stomach resulting from a relapse of acute myeloid leukemia after allogeneic cell transplantation in long-term survival of more than 10 years

Akinori Wada, Naoki Kobayashi, Shinsuke Asanuma, Satomi Matsuoka, Mizuha Kosugi, Shiro Fujii, Shinsuke Noguchi, Takayoshi Miyazono, Masanobu Nakata, Shuichi Ota, Kiyotoshi Imai, Teiichi Hirano, Masahiro Ogasawara, Yoshio Kiyama, Masaharu Kasai

Letter to the Editor

CD16 antigen is a positive marker of peripheral blood-derived early endothelial progenitor cells

Takashi Kimura, Hirao Kohno, Yoshikazu Matsuoka, Ryusuke Nakatsuka, Yutaka Sasaki, Shirou Fukuhara, Yoshiaki Sonoda

Letter to the Editor

Vincristine-resistant Kasabach–Merritt phenomenon successfully treated with low-dose radiotherapy

Yuko Watanabe, Masaei Onuma, Chung Y. Looi, Yuka Saito, Hiroshi Kitazawa, Hidetaka Niizuma, Takeshi Rikiishi, Osamu Sakamoto, Yoji Sasahara, Satoru Kumaki, Mika Watanabe, Shigeko Ushio, Shigeru Tsuchiya

Letter to the Editor

Prospective study of combination therapy with low-dose thalidomide plus prednisolone ameliorating cytopenia in primary myelofibrosis

Yutaka Hattori, Yoshitaka Miyakawa, Kenji Yokoyama, Taketo Yamada, Wenlin Du, Masahiro Jinzaki, Hiroshi Shinmoto, Shinichiro Okamoto

Letter to the Editor

Oral ribavirin therapy for lower respiratory tract infection of respiratory syncytial virus complicating bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation

Takehiko Mori, Yukinori Nakamura, Jun Kato, Akiko Yamane, Yoshinobu Aisa, Kei Takeshita, Shinichiro Okamoto

Letter to the Editor

Flow cytometric analysis of de novo acute myeloid leukemia in childhood: report from the Japanese Pediatric Leukemia/Lymphoma Study Group

Hideaki Ohta, Shotaro Iwamoto, Nobutaka Kiyokawa, Masahito Tsurusawa, Takao Deguchi, Kozo Takase, Junichiro Fujimoto, Keizo Horibe, Yoshihiro Komada

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.